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The cytokine tumor necrosis factor-alpha (TNFα) is one of the key factors during the priming
phase of liver regeneration as well as in hepatocarcinogenesis. TNFα activates the nuclear
factor κ-light-chain-enhancer of activated B cells (NFκB) signaling pathway and contributes
to the conversion of quiescent hepatocytes to activated hepatocytes that are able to prolif-
erate in response to growth factor stimulation. Different mathematical models have been
previously established for TNFα/NFκB signaling in the context of tumor cells. Combining
these mathematical models with time-resolved measurements of expression and phos-
phorylation of TNFα/NFκB pathway constituents in primary mouse hepatocytes revealed
that an additional phosphorylation step of the NFκB isoform p65 has to be considered in the
mathematical model in order to sufficiently describe the dynamics of pathway activation in
the primary cells. Also, we addressed the role of basal protein turnover by experimentally
measuring the degradation rate of pivotal players in the absence ofTNFα and including this
information in the model. To elucidate the impact of variations in the protein degradation
rates on TNFα/NFκB signaling on the overall dynamic behavior we used global sensitiv-
ity analysis that accounts for parameter uncertainties and showed that degradation and
translation of p65 had a major impact on the amplitude and the integral of p65 phospho-
rylation. Finally, our mathematical model of TNFα/NFκB signaling was able to predict the
time-course of the complex formation of p65 and of the inhibitor of NFκB (IκB) in primary
mouse hepatocytes, which was experimentally verified. Hence, we here present a math-
ematical model for TNFα/NFκB signaling in primary mouse hepatocytes that provides an
important basis to quantitatively disentangle the complex interplay of multiple factors in
liver regeneration and tumorigenesis.
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1. INTRODUCTION
Liver regeneration after tissue damage is a tightly regulated spatio-
temporal process, which is primarily controlled by specific growth
factors and cytokines (Michalopoulos, 2010). It predominantly
relies on the fast initiation of hepatocyte proliferation after injury
and only few proliferative cycles are necessary to restore the liver
mass and function (Papp et al., 2009).
Tumor necrosis factor-alpha (TNFα), which is predominantly
secreted from liver-resident macrophages (Kupffer cells), repre-
sents one of the earliest stimuli for proper initiation of hepatocytic
proliferation (Yamada et al., 1997). The most extensively charac-
terized response activated by TNFα is the highly conserved nuclear
factor of κ-light-chain enhancer of activated B cells (NFκB) path-
way, which can initiate hepatocytic mitotic cycles after entering
the nucleus. After partial hepatectomy (PHx), which is the best
experimental model for studying liver regeneration, the level of
TNFα increases dramatically within 1 h, leading to fast activation
of NFκB signaling (Diehl and Rai, 1996). The pivotal relevance
of TNFα-induced signaling is supported by the fact that in type I
TNFα receptor-deficient mice, hepatocyte proliferation is strongly
reduced and liver regeneration is impaired after PHx (Yamada
et al., 1997).
Activation of the NFκB axis involves the formation of homo- or
hetero-dimeric transcription factors composed of different sub-
units: p50 (NFκB1), p52 (NFκB2), p65 (RelA), RelB, and c-Rel
(Hayden and Ghosh, 2012). In absence of pathway activation,
these dimers are disabled by a family of inhibitory proteins includ-
ing IκBα, IκBβ, IκBε, and IκBγ. For example, binding of IκBα to
hetero-dimeric p65:p50 results in steady-state cytoplasmic com-
plex retention and therefore prevents dimers from binding their
respective DNA recognition sites. Upon TNFα stimulation, dif-
ferent regulatory proteins are recruited in close proximity to
the TNFα receptor and form the receptor-associated signalo-
some. Subsequently, IκBα phosphorylation is mediated by a kinase
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complex composed of IκB kinase-α (IKKα), IκB kinase-β (IKKβ),
and IκB kinase-γ (IKKγ or NEMO), followed by proteasomal
degradation of inhibitory IκBα as well as release and nuclear
translocation of p65:p50 complexes. These nuclear heterodimers
induce transcription of genes involved in the initiation of prolif-
eration as well as negative regulation of apoptosis (Hayden and
Ghosh, 2012).
The modulation of NFκB signaling results in different expres-
sion signatures in vivo and in vitro (Ashall et al., 2009; Li et al.,
2009; Sung et al., 2009). This could be achieved by posttransla-
tional modifications such as alternative phosphorylation of the
involved signaling components. Multiple phosphorylation sites
have been described for the NFκB subunit p65 (Viatour et al.,
2005). Most common is the phosphorylation of p65 at serine 536
that is mediated by IKK-β, Akt, and RSK1 in response to TNFα
(Sakurai et al., 1999), and IL1β (Madrid et al., 2001) stimulation
and DNA damage (Bohuslav et al., 2004). Other phosphoryla-
tion sites and kinases are gaining importance for regulating p65
transcriptional activity.
The protein kinase C, zeta (PKCζ) is capable to phosphorylate
free p65 at serine 311 when translocated into the nucleus follow-
ing TNFα stimulation (Duran et al., 2003). Furthermore another
specific p65 phospho-site, serine 276, has been shown to be a tar-
get for protein kinase A, c (PKAc), and mitogen-activated protein
kinase 14 (MAPK14/MSK1; Vermeulen et al., 2003; Jamaluddin
et al., 2007). These kinases are of particular interest since they
are localized in the nucleus and provide the possibility to modify
the transcriptional activity of p65 that translocates to the nucleus
subsequent to phosphorylation at serine 536 by IKK-β. However,
currently there is not much known regarding their direct involve-
ment in the regulation of canonical NFκB signaling (Joo and
Jetten, 2008) and the efficiency of antibodies used for detection
are controversially discussed (Spooren et al., 2010).
Another important feature of NFκB signaling is ligand-
independent, basal, and ligand-dependent turnover of the signal-
ing components. Basal degradation of IκBα has been reported
(Krappmann et al., 1996; Pando and Verma, 2000) suggesting
that two different IκBα pools, p65-bound and free unbound,
exist. In both cases, IKK-β-mediated IκBα phosphorylation was
not necessary for basal protein degradation. However, the pool
of free IκBα represents only 15% of the total protein amount
(Rice, 1993) and thus specific mechanisms are required to explain
basal degradation of free and p65-bound IκBα (Mathes et al.,
2008). Combining genetic tools and mathematical models Mathes
et al showed that free IκBα degradation is independent of its
phosphorylation or ubiquitination but mainly mediated by a spe-
cific C-terminal sequence (PEST) able to fine-tune turnover of
free IκBα protein. On the other hand, different from the rather
instable free IκBα, p65 is relatively stable and upon complex
formation with IκBα protects IκBα from fast degradation. IKK-
β-mediated phosphorylation of p65-bound IκBα in response to
TNFα stimulation leads to the release of the complex unmask-
ing the PEST sequence and results in an efficient recognition
and fast degradation by the proteasome. Thus, basal and ligand-
dependent turnover operate on different time scales. Their specific
contribution to signal amplitude and duration remains to be
elucidated.
In the past, the dynamic behavior of NFκB has been intensively
analyzed in different cancer cells and immortalized fibroblasts
(Cheong et al., 2006; Ashall et al., 2009). Particularly, time-resolved
phosphorylation analysis of pathway constituents (including p65
and IκBα) followed by the activation of target genes involved in
feedback regulation (e.g., IκBα, A20) leads to the identification of
sustained oscillatory behavior in NFκB signaling (Nelson et al.,
2004).
In this regard, NFκB signaling has been extensively studied by
computational modeling. Carlotti et al. (1999, 2000) presented
a first computational study focused on the investigation of the
NFκB shuttling, whereas Hoffmann et al. (2002) studied the whole
signaling module. The model by Nelson et al. (2004) pointed to
the importance of the IκBα transcription rate for the frequency
of oscillations and further analysis suggested IκBα and A20 have
a major impact on the pathway dynamics (Werner et al., 2008).
Another study reported a key role for IκBα and IKKs in oscilla-
tions and protein turnover (Ihekwaba et al., 2004; Cheong et al.,
2006). Recently, the influence of model parameters on the path-
way dynamics has been studied identifying NFκB concentration
to be the most decisive parameter for oscillations (Wang et al.,
2011).
Only few studies included protein synthesis and degradation
rates as relevant parameters for NFκB signaling dynamics (O’Dea
et al., 2007). In some cases, IκB turnover is part of the model, but
NFκB, e.g., p65 turnover has not been included so far, which is
probably due to the relatively stable levels of NFκB. However, it
is problematic to predict the influence of stable proteins on sys-
tems behavior. O’Dea et al. (2007) measured and modeled the
influence of NFκB binding on the degradation rate of IκB species,
which was important for their computational predictions. Thus,
NFκB seems to protect IκB species from unstimulated degrada-
tion. None of the described studies analyzed and modeled NFκB
signaling in primary and non-malignantly transformed hepato-
cytes representing the major cell population of the liver involved
in regeneration and tumorigenesis.
Here we present a hepatocyte-specific model for TNFα-induced
NFκB signaling that considers basal protein turnover and facili-
tates the prediction of TNFα-induced complex formation of p65
and IκBα. Since not all parameters of the model are fully identifi-
able we study an ensemble of 30 different parameter sets that each
fit our experimental data. Model validation and conclusions are
based on common properties of the ensemble of models.
2. MATERIALS AND METHODS
2.1. EXPERIMENTAL: ANIMAL WORK, ISOLATION OF PRIMARY
MURINE HEPATOCYTES, AND CULTURE CONDITIONS
C57Bl/6 mice were obtained from Charles River (Wilmington,MA,
USA) and housed under standard conditions in the DKFZ animal
facility. All experiments were performed with the approval of the
German Regional Council of Baden-Wuerttemberg (Karlsruhe,
Germany) and in accordance with the institutional regulations.
Isolation of hepatocytes from mice has previously been described
(Castoldi et al., 2011). In brief, six to twelve weeks old animals were
anesthetized using 10% ketamine hydrochloride (5/100 mg body
weight) and 2% xylazine hydrochloride (1/100 mg body weight),
and perfused with HANKS solution supplemented with 0.3 mg/ml
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collagenase CLSII and 5 mM CaCl2. After liver removal, hepa-
tocytes were plated on collagen-coated culture dishes (1 million
cells/6 cm BD; Biocoat; Horsham, PA, USA) and cultured with
adhesion medium (Williams’ medium E (Biochrom, Berlin, Ger-
many), 10% FCS, 0.1% insulin, 100 nM dexamethasone, 2 mM
l-glutamine, and 1% penicillin/streptomycin) at 37˚C for 4 h.
After attachment, cells were washed with PBS (GIBCO Life Tech-
nologies, Darmstadt, Germany) and incubated over-night with
pre-starvation medium (Williams’medium E, 100 nM dexametha-
sone, 2 mM l-glutamine, and 1% penicillin/streptomycin). Before
TNFα stimulation, cells were incubated in starvation medium
(Williams medium E and 1% penicillin/streptomycin) for 5 h.
Dynamic stimulation of NFκB signaling was achieved by admin-
istration of recombinant murine TNFα (10 ng/ml; R&D Systems,
Minneapolis, MN, USA) in starvation medium. At different time-
points after TNFα treatment (5, 10, 20, 40, 60, 120, 180, 240 min),
medium has been removed and cells were washed with PBS
immediately before mRNA and protein isolation.
2.1.1. mRNA preparation and real-time PCR
For isolation of total mRNA from hepatocytes the NucleoSpin
RNA II kit has been used (Macherey-Nagel Düren, Germany).
cDNA synthesis (RevertAid H minus, Fermentas, St. Leon-Rot,
Germany) and semiquantitative real-time PCR (Abgene/Thermo
Fisher, Epsom, UK) have been performed using SYBR Green ROX
Mix (Thermo Scientific, Ulm, Germany) according to the manu-
facturers’ protocol. The following primers were used in this study:
IkBα forward: 5′-CCT GGC CAT CGT GGA GCA CT-3′, IkBα
reverse: 5′-AGT AGC CTT GGT AGG TTA CC-3′; tubulin for-
ward: 5′-TCA CTG TGC CTG AAC TTA CC-3′; tubulin reverse:
5′-GGA ACA TAG CCG TAA ACT GC-3′ (Thermo Scientific, Ulm,
Germany). Cycling program: 95˚C/15 min followed by 40 cycles
95˚C/15 s and 60˚C/1 min. Melting curve: 95˚C/15 s, 60˚C/30 s,
95˚C/15 s.
2.1.2. Protein preparation, immunoprecipitation, and
immunoblotting
Total protein fractions were collected at the indicated time-points
using the Cell Lysis Buffer (Cell Signalling Technology, Frank-
furt am M., Germany) supplemented with Protease Inhibitor Mix
G (Serva, Heidelberg, Germany). After sonication (3 times for
20 s) and protein quantification (NanoDrop, Thermo Scientific),
80µg/lane of total protein were loaded on a denaturing 10%
PAA/SDS gel.
To determine time-dependent basal protein degradation of
specific NFκB pathway constituents, cells were treated with
cycloheximide (50µg/ml). Proteins were isolated at indicated
time-points.
For p65: IκB-α co-immunoprecipitation, proteins were isolated
using NP-40 buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-
40). Three micrograms of p65-specific antibody (clone F6, Santa
Cruz Biotechnology, Heidelberg, Germany) and 40µl G PLUS-
Agarose (Santa Cruz Biotechnology) were mixed with 1.5 mg
of total protein and incubated over-night. After centrifugation,
the pellet was washed three times with HNTG buffer (20 mM
Hepes pH 7.5, 150 mM NaCl, 0.1% Triton X-100, and 10% glyc-
erol). Subsequently, the pellet was diluted in 1x sample buffer
(100 mM Tris-HCl pH 6.8, 5% glycerol, 0.005% BBP, 5% SDS, 5%
β-mercaptoethanol) and incubated at 95˚C for 6 min. Pellet was
pulled down and supernatant was loaded on a 10% PAA/SDS gel.
After protein transfer, membranes were blocked in 1x TBS con-
taining 0.1% Tween and 5% BSA (Serva, Heidelberg, Germany) or
5% milk for 30 min. The respective primary antibodies were incu-
bated over-night at 4˚C. After washing with TBST, membranes
were incubated with specific secondary antibody (1 h at RT) and
signal detection was performed by ECL (Western Lightning Plus-
ECL, Perkin Elmer). Signals were digitally documented using the
Fluorchem FC device (Alpha Innotech/Biozym, Hess. Oldendorf,
Germany).
Primary antibodies used in this study were: anti-p65 (clone
A, dilution for WB: 1:200, Santa Cruz Biotechnology), anti-p65
(clone F6; dilution for IP: 1:25, Santa Cruz Biotechnology), anti-
phospho-p65 (Ser536, dilution for WB: 1:500, Santa Cruz Biotech-
nology), anti-IκB-α (#9242, dilution: 1:750, Cell Signalling Tech-
nology), anti-phospho-IκBα (Ser32, clone: 14D4, dilution: 1:400,
Cell Signalling Technology), and anti-actin (clone: C4, dilution:
1:2000, MP Biomedical, Germany). Secondary antibodies were:
anti-rabbit IgG HRP-linked antibody (dilution: 1:2000, Cell Sig-
nalling Technology) and anti-mouse IgG (dilution: 1:2000, Cell
Signalling Technology).
2.1.3. Data acquisition and processing
Every experiment was replicated at least eight times and raw data
have been used for modeling purposes. For every protein, four dig-
ital pictures at different exposure times were taken and signals were
quantified using the image analysis software Quantity-One (Bio-
rad, Munich, Germany). Each numerical data point was normal-
ized to respective actin amounts, which served as loading control
for the samples. For comparability between different experiments,
all data points were further normalized to the appropriate control
on each blot (hepatocytes without TNFα stimulation) to a fixed
value (c= 100 arbitrary units).
2.2. COMPUTATIONAL
A system of ordinary differential equations (ODEs) was set up with
the software COPASI (Hoops et al., 2006) and integrated using
the LSODA integrator as implemented in this software (Petzold,
1983). Sensitivity analysis was employed to determine the influ-
ence of certain parameters on systems outcomes, e.g., amplitudes
as described in the text. The sensitivity analysis was also used as
implemented in COPASI. Parameter fitting was performed using
the particle swarm algorithm (Kennedy and Eberhart, 1995), again
as implemented in COPASI.
3. RESULTS
3.1. INITIAL TNFα/NFκB SIGNALING MODEL
In order to investigate hepatocyte-specific behavior of NFκB sig-
naling, we developed an initial model based on the most important
NFκB pathway constituents reported in the literature for hepato-
cytes (Wullaert et al., 2007; Figure 1A). The involved processes
were modeled similar to published models (O’Dea et al., 2007;
Ashall et al., 2009). All processes upstream of the IκB kinase (IKKβ)
were lumped in the model assuming that they happen very fast
(Delhase et al., 1999). Phosphorylated IKKβ is active and phospho-
rylates free and p65-bound IκBα. Phosphorylated IκBα dissociates
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FIGURE 1 | Initial mathematical model ofTNFα/NFκB signaling in
hepatocytes. (A) Schematic representation of the initial model created
with the software CellDesigner4.2 indicating the considered
components and reactions (Funahashi et al., 2008). Boxes with round
corners symbolize proteins, straight boxes indicate DNA, and
parallelograms represent RNA. (B) Time-course of TNFα-induced
signaling and model trajectories. 106 primary mouse hepatocytes were
stimulated with 10 ng/ml TNFα for the indicated time. From total cellular
lysates phosphorylation (pphodpho-serine 536 p65 and phospho-serine
32 IκBα) and total protein (IκBα) were examined by immunoblotting.
Equal loading was confirmed by reprobing of the immunoblots with an
anti-actin antibody. Quantification was performed using
chemiluminescence, detection by the Fluorchem FC device and the
image analysis software Quantity-One. Representative immunoblots
are indicated above each panel. Quantifications from four independent
preparations of primary mouse hepatocytes are indicated by symbols.
The time-course of IκBα mRNA induction was determined by real-time
PCR. Representative results for two independent experiments are
depicted. See Tables S11 and S12 in Supplementary Material for exact
values of the experimental data. Black lines indicate model trajectories
for 30 parameter sets, fitting and simulation was done with the
software COPASI. The concentrations are given in arbitarty units (a. u.).
from p65, and is rapidly degraded (Ghosh et al., 1998). Free p65 is
imported to the nucleus where it induces transcription of different
target genes such as IκBα and A20 (Scott et al., 1993; Tian et al.,
2005). In our initial model we introduced stimulated and basal
transcription, translation, nuclear mRNA export, and degrada-
tion of IκBα as well as IκBα-mRNA. Newly synthesized IκBα can be
phosphorylated and degraded or it can reenter the nucleus where it
forms a complex with p65 which is then exported to the cytoplasm
(Arenzana-Seisdedos et al., 1995). Furthermore, p65 turnover was
included in form of translation and degradation reactions while
assuming a constant concentration of the corresponding mRNA.
Most reactions were modeled as reversible reactions with mass
action kinetics, while phosphorylation of complexed and free IκBα
was modeled by a Michaelis-Menten kinetics with IKKβ being the
catalytic enzyme in this term. The included protein synthesis and
degradation for p65 and IκBα, and the reversible kinetics as well
as a basal IKKβ phosphorylation led to basal levels of all species
with exception of the ligand TNFα. We assumed the model to be
in a steady-state before administration of TNFα. For more details
on the reactions and the parameters see Tables S1, S3, S5–S7 in
Supplementary Material.
3.2. PARAMETRIZATION OF THE MODEL BASED ON EXPERIMENTAL
DATA
To parametrize the initial model of TNFα-induced NFκB signal-
ing, quantitative time-courses of NFκB pathway constituents were
measured after TNFα treatment of primary murine hepatocytes.
Since it has been shown that TNFα operates very early during
liver regeneration (Fausto et al., 2006), we investigated the sys-
tem for 4 h after TNFα stimulation and measured concentrations
and/or activities using narrow time-point sampling, especially in
the beginning of this time frame.
We detected the phosphorylation of IκBα and p65 by
immunoblotting using total cellular lysates isolated at different
time-points after TNFα stimulation. Rather constant levels of
total p65 during the time-course were observed (data not shown).
However, TNFα stimulation resulted in a rapid increase of phos-
phorylated p65 after 10 min, followed by a strong decrease until the
original level was reached after approximately 40 min (Figure 1B).
IκBα was phosphorylated approximately with the same dynamics
as p65; however, slightly faster and with a second peak of activa-
tion around 60 min, which lasted until 120 min after stimulation
(Figure 1B).
Frontiers in Physiology | Systems Biology December 2012 | Volume 3 | Article 466 | 4
Pinna et al. NFκB signaling in primary hepatocytes
In line with the notion that phosphorylation of IκBα is
associated with K48-linked polyubiquitination and subsequent
degradation, a rapid reduction of the IκBα protein level from 10 to
40 min after TNFα treatment and fast recovery after 60 min until
the end of the experiment were detected (Figure 1B). To determine
to what extent the p65 activity triggered IκBα gene transcription,
real-time PCR analysis was performed revealing increased IκBα
mRNA levels starting from 20 min with a maximum peak level
around 60 min after stimulation. These experimental data were
used to perform parameter estimation for the initial model.
To further constrain the parameters of the model, basal
turnover of the examined signaling components was measured.
For this primary mouse hepatocytes were pretreated with the
inhibitor of protein synthesis cycloheximide (CHX) and time-
courses up to 360 min without TNFα administration were mea-
sured for p65 and IκBα by immunoblotting (Figure 2A). The
results revealed high p65 stability throughout the entire experi-
mental time frame, indicating little or no p65 turnover. On the
other hand, IκBα showed a 40% degradation within 6 h after
CHX treatment (Figure 2B). Therefore, a constraint was intro-
duced for parameter estimation to only consider parameter sets
that ensured a stable level of p65. Individual parameter values
for the degradation of p65 and IκBα in their different binding
states could not be derived from the measurements of total p65
and IκBα concentrations. Instead, parameters of p65 and IκBα
degradation were constrained in the parameter fitting procedure
such that the resulting overall degradation rates were close to the
measured values.
The initial model was able to fit most of the data well. The
fitting, which was computationally very time consuming, was
repeated 60 times with random start values, the 30 best fits were
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FIGURE 2 | Basal protein degradation of NFκB pathway components.
In the absence of TNFα, primary mouse hepatocytes were treated with
50µg/ml cyloheximide and were lyzed at the indicated time-points. (A)
Representative immunoblot of three independent experiments is shown for
IκB and p65. (B) Median values and standard deviation of measured p65
and IκBα from three independent experiments.
selected for further analysis. However, a more detailed inspec-
tion of the resulting model trajectories revealed that simultaneous
fitting of phosphorylated p65, IκBαmRNA, and IκBα time-courses
was not sufficiently possible with this preliminary model. More
specifically, considering the time-courses of phosphorylated p65,
phosphorylated IκBα, and total IκBα revealed two distinct clusters
of parameter sets, none of which could capture all the features of
the observed data. In the first cluster of parameter sets only the
initial fast increase of phosphorylated p65 was captured, the fol-
lowing equally fast decrease however was predicted to be slower
than the experimental data would suggest; furthermore, IκBα lev-
els in the model did not decrease as strong as the experimental data
would suggest. In the second group of parameter sets the dynamics
of phosphorylated p65 were captured better, while total IκBα levels
went into a too strong overshoot above the steady-state concen-
tration at approximately 100 min. Also the amplitude of the IκBα
mRNA dynamics was significantly smaller than the measurements
suggested. These inconsistencies are due to a tight coupling of free
p65 and IκBα levels in the initial model and cannot be resolved
without changes to the model structure.
3.3. EXTENDED MODEL INCLUDING ADDITIONAL p65
PHOSPHORYLATION
To resolve these discrepancies and improve the description of the
experimentally observed induction of IκBα mRNA and subse-
quent protein levels, we introduced into the initial model reac-
tions that could modify the transcriptional activity of p65 in the
nucleus. Since besides phosphorylation at serine 536 additional
phosphorylation of p65 by nuclear kinases has been proposed,
which could modify target gene expression including IκBα, we
considered the activation of a nuclear kinase. The activation of the
nuclear kinase was modeled generically by three reaction steps with
mass action kinetics to account for a delay in activation, avoiding
specific aspects of the upstream activation of the nuclear kinase
(Figure 3A, Tables S2, S4 in Supplementary Material).
This extended model was now able to quantitatively fit all exper-
imental data (Figure 3B). In order to analyze the uniqueness of
the fit and thus parameter identifiability (Raue et al., 2009), the
fitting procedure was repeated 30 times with random start values
resulting in 30 parameter sets fitting the experimental data well.
Most of the parameters were not identifiable as depicted in Tables
S8–S10 in Supplementary Material. However, the kinetic constants
for IKKβ dephosphorylation and IκBα basal transcription could
be narrowed down to a large extent.
3.4. IMPACT OF PROTEIN TURNOVER ON THE DYNAMICS OF
TNFα/NFκB SIGNALING
The role of protein turnover has been neglected in most of the
studies involving NFκB signaling. However, IκBα degradation
might be a critical step because its protein levels immediately
decreased after activation of the system (IκBα phosphorylation).
In addition, the system’s main activated effector, p65, is in turn
able to increase IκBα protein levels by promoting its transcription,
thus establishing a negative feedback loop in the system.
Therefore, we computationally analyzed the impact of protein
degradation and turnover on important signaling readouts such
as the amplitude peak of phosphorylated p65 or the integrated
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FIGURE 3 | Extended mathematical model ofTNFα/NFκB signaling in
hepatocytes. (A) Schematic representation of the extended model created
with the software CellDesigner4.2 indicating the additional steps added to the
initial model. (B) Time-course of TNFα-induced signaling and model
trajectories of the extended model. Experimental data for phospho-65,
phospho-IκBα, IκBα, and IκBα mRNA as shown in Figure 1 is depicted by
symbols. The predicted model trajectories for 30 parameter sets are indicated
by black lines. The concentrations are given in arbitarty units (a. u.).
response (area under curve) which represent the signal strength.
The ensemble of model parametrizations produced by 30 indepen-
dent fits was analyzed again. Each of these parametrizations was
subjected to a sensitivity analysis calculating the impact of spe-
cific kinetic parameters and protein turnover on the peak-height
(amplitude) as well as integrated response of the signal (concen-
tration of NFκB). The results demonstrated that the properties of
these models were surprisingly robust as depicted in Figure 4 (for
the respective heat maps of the IκBα, phosphorylated IκBα, and
IκBα mRNA amplitude and integral see Figures A1–A3).
These heat maps showed a high consistency within the 30 differ-
ent fits despite the unidentifiability of most parameters, indicating
that these sensitivities were valid for most parameter sets and
therefore most likely for physiological parameter sets. Interest-
ingly, few parameter sets, e.g., parameter set 30, showed differences
in comparison with most parameter sets. Analyzing the specific
behavior of these unique models, revealed a high sensitivity toward
many parameters, indicating these systems to be in an instable
state with respect to perturbation. Therefore, it can be assumed
that these few models, although representing the data well, do not
correspond to the physiological states in cells.
When analyzing especially the parameters involved in protein
synthesis and degradation, which regulate protein level, it became
apparent that among the prominent parameters influencing the
integral of the signal were those involved in transferring the TNFα
stimulation into phosphorylated p65 liberation in form of IKKβ
phosphorylation (parameters 24, 26, 27 in Figure 4) and p65
translation and degradation (parameters 42, 37). Interestingly,
changing translation and degradation of p65 proportionally, so
that turnover was changed but the protein level stayed constant,
showed very little impact (parameter 50). Parameters describing
basal IκBα transcription, translation, and turnover (parameters
22, 23, 49) were also influencing the integral drastically, whilst
its degradation and active transcription (parameters 7–10, 19–21)
showed very little impact.
Among the parameters determining the signal amplitude were
degradation and translation of p65 (parameters 37, 42); again,
despite its turnover (parameter 49) having very little influence. In
general, the amplitude of phosphorylated p65 was controlled by
fewer parameters than the integral of phosphorylated p65.
With respect to the amplitudes and integrals of phosphorylated
p65, total IκBα, phosphorylated IκBα, and IκBαmRNA, the system
typically depended on the p65 translation and degradation (para-
meters 37, 42), the activated IKKβ phosphorylation (parameters
24, 26), and the IκBα mRNA degradation in the cytoplasm (para-
meter 11), whilst changing p65 turnover (assuming unchanged
steady-state levels of p65, parameter 49) had limited impact.
3.5. VALIDATION OF THE MODEL AND PREDICTION OF COMPLEX
FORMATION
To assess improvements achieved through the development of the
extended model, we compared the ratios of free IκBα before TNFα
administration predicted by the initial model and the extended
model. In the initial model all parameters sets propose that at least
50% of total IκBα is in an unbound state. On the other hand in the
extended model the median lies at 20% (Figure 5) which is well
in line with the experimentally observed 15% reported by Rice
(1993).
Finally, we validated our mathematical model of TNFα-
induced NFκB signaling in primary mouse hepatocytes by using
experimental data not utilized for parametrization of the model.
p65:IκBα co-immunoprecipitation was performed to measure
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FIGURE 4 | Impact of parameter changes on amplitude and
integral of phospho-p65. For each of 30 parameter sets the
sensitivities with respect to every model parameter are shown in a
heat map. Blue shades denote negative, red shades positive
sensitivity coefficients. Color shading is scaled from −1.0 to +1.0. The
parameter sets were clustered hierarchically according to the shown
sensitivities, however, this is merely to improve visual survey and
there is no direct correlation to the similarity of parameters. The
clustering was preformed with the help of the software Cluster 3.0
(de Hoon et al., 2004).
complexed p65 concentrations over time (Figure 6B). Since
most of the parameter values were not identifiable, we cre-
ated a model ensemble by conducting the parameter fitting 30
times. All 30 fits, representing different parameter sets all fit-
ting the experimental data, were used to predict the observed
experimental co-immunoprecipitation data. For this purpose, the
kinetic parameters were kept unchanged; only the scaling factors
were refitted to the validation data (Figure 6A).
The experimental results showed the initial level of p65:IκBα
complexes strongly decreased 5 to 10 min after stimulation with
www.frontiersin.org December 2012 | Volume 3 | Article 466 | 7
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FIGURE 5 | Comparison of free IκBα predicted by the initial and the
extended model. The level of free, unphosphorylated IκBα for 30
parameter sets of both models was predicted and is depicted as a box plot.
According to literature at most 15% of IκBα is unbound of p65 (Rice, 1993).
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FIGURE 6 | Model prediction and experimental validation of p65: IκBα
complex formation. About 106 primary mouse hepatocytes were
stimulated with 10 ng/ml TNFα for the indicated time. From NP-40 lysates
complexes of p65 and IκBα were co-immunoprecipitated (IP) using an
anti-p65 antibody and probing the immunoblots (IB) with an anti-IκBα
antibody. A representative immunoblot is shown and quantifications for two
independent hepatocyte preparations are indicated by symbols. Black lines
indicate the time-course predictions from 30 parameter sets.
TNFα. During this time frame, concentrations of serine 536
phosphorylated p65 increased and IκBα concentration decreased,
while after 40 min the IκBα and complex concentrations increased
again. Between 60 and 120 min the complexed p65:IκBα reached
their initial level, followed by a second minor decrease. The model
predicted the full dynamics until the second decrease at approxi-
mately 180 min, which was likely due to additional feedback loops
in the system.
4. DISCUSSION
The involvement of NFκB signaling is critical in the context
of liver injury and regeneration as well as inflammation and
tumorigenesis (Luedde and Schwabe, 2011). Especially during
chronic liver disease, activation of this pathway triggers hepatocyte
proliferation and (at later time-points) is eventually supporting
tumor development and progression. Hepatocellular carcinoma
(HCC) is the third most common cause of cancer-related death
worldwide (Breuhahn et al., 2011) and represents a paradigm of
inflammation-induced cancer, indicating a strong link between
activation of pro-inflammatory pathways such as TNF-induced
NFκB signaling and tumorigenesis. However, the impact of NFκB
signaling on early phases of hepatocarcinogenesis is highly com-
plex, since this pathway is activated in different cell types including
hepatocytes (which represent the major cell population), hepatic
stellate cells, and resident immune cells (Kupffer cells) (Amann
et al., 2009). In order to understand the impact of this pathway
in the earliest stages of liver damage and tumorigenesis, it is of
central relevance to generate mathematical models describing its
dynamic behavior in normal and non-malignantly transformed
cells. These tools represent the basis for further comprehensive
systems biology studies, essential for a deeper understanding of
liver cancer initiation and progression.
Our initial model for TNFα-induced NFκB signaling in mouse
hepatocytes was constructed by applying central aspects of estab-
lished computational models of NFκB signaling in other organ-
isms or cell types (O’Dea et al., 2007; Ashall et al., 2009). Our goal
was a reparametrization of this model using hepatocyte-specific
experimental data obtained from comprehensive, quantitative,
and time-resolved protein and transcript analyses. However, the
model was not able to satisfyingly fit all experimental data simul-
taneously. Specifically, it was not able to describe the difference
in the dynamics of phospho-p65 and free IκBα concentrations
during the first hour after administration of TNFα. While the ini-
tial rise of phospho-p65 and the corresponding decrease of IκBα
occur on a similar fast time scale, phospho-p65 returns to near
its steady-state value faster than IκBα. In the initial model, the
dephosphorylation of p65 is assumed to coincide with its binding
to IκBα implying it cannot happen faster than the regeneration
of IκBα. Since this is contrary to our observations, we uncoupled
p65 dephosphorylation from its binding to IκBα by introducing
a more detailed description of p65 phosphorylation and dephos-
phorylation including a state in which p65 is not phosphorylated
but also not bound to IκBα in the nucleus.
It is well known that p65 can be phosphorylated by a number of
different kinases at different residues such as serine 536, which is
measured by our immunoblotting approach (Viatour et al., 2005).
Among the different kinases that may effect serine 536 phosphory-
lation, only IKKβ is activated by TNFα-induced signaling (Viatour
et al., 2005). This is the process that is implicitly included in
our initial model. The extended model contains in addition the
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phosphorylation of p65 at serine 276 by a nuclear kinase. Our
data suggests uncoupling of p65 phosphorylation and its bind-
ing to IκBα, which was achieved by implementing an additional
phosphorylation and corresponding dephosphorylation process
in the model. Adjusted like this, the model can indeed reproduce
the observed differences in the dynamics of phospho-p65 and free
IκBα. In addition, the revised model also convincingly reproduced
the amplitude of the IκBα mRNA measurements, which was not
possible using the initial model.
A potential candidate for such a nuclear kinase could be
mitogen- and stress-activated protein kinase 1 (MSK1) that has
also been shown to be expressed in human liver cells (Deak
et al., 1998). However, MSK1 appears to have no direct impact
on IκBα expression and the phosphorylation of p65 by MSK1 is
controversially discussed (Joo and Jetten, 2008).
The extended model is able to explain features of NFκB signal-
ing in hepatocytes as displayed by our measurements. However,
NFκB signaling is known to involve more constituents and regula-
tions than considered in this study. Therefore, other components
can be included in future research. Tumor necrosis factor α-
induced protein 3 (TNFAIP3/A20) is one considerable protein,
involved in a negative loop inhibiting p65 phosphorylation acting
upstream of IKK-β (Opipari et al., 1990). This protein, together
with IκBα is probably the most important factor in the acquisition
of phosphorylated p65 oscillatory behavior critical for transcrip-
tional target fate (Ashall et al., 2009). Another NFκB constituent
involved in negative feedback loop with high impact in NFκB sig-
naling oscillations is IκBε. This protein belongs to the IκB inhibitor
family of signaling whose activity has been detected later and out
of phase if compared with IκBα. This special feature leads IκBε
to dampen the effect of IκBα during the last phase of sustained
NFκB activity and to mediate the terminations of the signaling in
response to transient stimulation (Kearns et al., 2006). From our
preliminary data, both protein TNFAIP3/A20 and IκBε present
a significant expression in primary hepatocytes following TNFα
stimulation and this data will be used for parametrization of fur-
ther improved models. Moreover signals coming not directly from
TNFα but able to fine-tune the system especially in the nucleus
should be taken into account.
A vital methodological question remains in the context of this
work: What is the justification to claim that the model proposed
here is a model for NFκB signaling in mouse hepatocytes? We have
consulted literature to make sure all the processes and compo-
nents included in the model are actually present in mammalian
hepatocytes. On the other hand, to our knowledge none of these
components or processes is actually exclusive to liver cells or hepa-
tocytes. Basically this leaves the parametrization of the model as
being hepatocyte-specific. Parameter estimation was performed
with data measured in murine hepatocytes and the presented
model was able to fit the data satisfyingly. However, some of
the parameters are unidentifiable with the available data, i.e., for
different values of the parameter the model fits the data equally
well. Instead of eliminating the unidentifiabilities – by performing
additional experiments and/or by simplifying the model – here
we focused on making predictions from the model that are valid
for all parametrizations of the model that are compatible with
the experimental data. As a pragmatic way to characterize the
set of parameter values that let the model fit the data, a heuris-
tic sampling of parameter space was performed, a technique that
was recently applied in other studies (Maiwald et al., 2010; Lev-
ering et al., 2012; Wegner et al., 2012). The parameter estimation
process was repeated 30 times, each time starting with different
random parameter values as initial guess, resulting in 30 differ-
ent sets of parameters that are compatible with the experimental
data. This immediately results in a good estimate for the iden-
tifiability of the different parameters: the more the parameters
differ between the repeated parameter estimation runs the less
identifiable they are.
For drawing conclusions from our model or creating predic-
tions for validation we need to make sure that these conclusions
or predictions are valid for all or at least most of the 30 parameter
sets. Indeed, the model validation described in the Results section
proved to be conserved for all 30 parameter sets. Similarly the sen-
sitivities that were calculated in order to study the role of protein
turnover turned out to be consistent for 25 of the 30 parameter
sets. While of course we cannot be absolutely certain from using
only a limited number of samples, we can confidently claim that
typically the model will predict a certain behavior of NFκB signal-
ing in hepatocytes whenever the parameters are chosen so that it
fits the data.
While our model shares its basic structure with most relevant
NFκB models in literature, it is based on NFκB dynamics fol-
lowing TNFα stimulation in murine primary hepatocytes. Our
experimental setup allows us to disturb hepatocytes with differ-
ent combination of ligands and to compare data with prediction
from our model. Different models for different signaling path-
ways essential for liver homeostasis and response to injury are
currently being developed, e.g., within the German Virtual Liver
Network (VLN). In this context our model can be a useful tool for
comparison and integration of different models. Thus, we have
established a mathematical model for TNFα/NFκB signaling in
primary mouse hepatocytes that indicated the importance of basal
turnover of the pathway components for the dynamic behavior
and facilitated the prediction of the kinetics of complex formation
in the pathway. Taken together the model provides an important
building block to unravel regulation of liver regeneration and the
impact of inflammatory responses across the scales.
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APPENDIX
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46.  k
M
: pSer276p65 dephosphorylation 
47.  TNFα amount 
48.  k: TNFα degradation 
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FIGURE A1 | Impact of parameter changes on amplitude and integral of
IκBα. For each of 30 parameter sets the sensitivities with respect to every
model parameter are shown in a heat map. Blue shades denote negative, red
shades positive sensitivity coefficients. Color shading is scaled from −1.0 to
+1.0. The parameter sets were clustered hierarchically according to the
shown sensitivities, however, this is merely to improve visual survay and
there is no direct correlation to the similarity of parameters. The clustering
was preformed with the help of the software Cluster 3.0 (Ashall et al., 2009).
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FIGURE A2 | Impact of parameter changes on amplitude and integral of
phospho-IκBα. For each of 30 parameter sets the sensitivities with respect
to every model parameter are shown in a heat map. Blue shades denote
negative, red shades positive sensitivity coefficients. Color shading is scaled
from −1.0 to +1.0. The parameter sets were clustered hierarchically according
to the shown sensitivities, however, this is merely to improve visual survey
and there is no direct correlation to the similarity of parameters.The clustering
was preformed with the help of the software Cluster 3.0 (Ashall et al., 2009).
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FIGURE A3 | Impact of parameter changes on amplitude and integral of
IκBα mRNA. For each of 30 parameter sets the sensitivities with respect to
every model parameter are shown in a heat map. Blue shades denote
negative, red shades positive sensitivity coefficients. Color shading is scaled
from −1.0 to +1.0. The parameter sets were clustered hierarchically according
to the shown sensitivities, however, this is merely to improve visual survey
and there is no direct correlation to the similarity of parameters.The clustering
was preformed with the help of the software Cluster 3.0 (Ashall et al., 2009).
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